- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 428498, 8 pages
Bacterial Artificial Chromosome Clones of Viruses Comprising the Towne Cytomegalovirus Vaccine
1Department of Pediatrics, Medical College of Virginia Campus of Virginia Commonwealth University, 1101 E. Marshall Street, P.O. Box 980163, Richmond, VA 23298-0163, USA
2MRC-University of Glasgow Centre for Virus Research, 8 Church Street, Glasgow G11 5JR, UK
3Department of Vaccine Research, Vical Incorporated, 10390 Pacific Center Court, San Diego, CA 92121, USA
4Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
Received 14 July 2011; Accepted 24 August 2011
Academic Editor: Paul W. Doetsch
Copyright © 2012 Xiaohong Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. B. Fowler, S. Stagno, R. F. Pass, W. J. Britt, T. J. Boll, and C. A. Alford, “The outcome of congenital cytomegalovirus infection in relation to maternal antibody status,” The New England Journal of Medicine, vol. 326, no. 10, pp. 663–667, 1992.
- K. B. Fowler and S. B. Boppana, “Congenital cytomegalovirus (CMV) infection and hearing deficit,” Journal of Clinical Virology, vol. 35, no. 2, pp. 226–231, 2006.
- C. C. Morton and W. E. Nance, “Newborn hearing screening—a silent revolution,” The New England Journal of Medicine, vol. 354, no. 20, pp. 2151–2164, 2006.
- K. R. Stratton, S. J. Durch, and R. S. Lawrence, Eds., Vaccines for the 21st Century: A Tool for Decisionmaking, National Academy Press, Washington, DC, USA, 2000.
- S. A. Plotkin, T. Furukawa, N. Zygraich, and C. Huygelen, “Candidate cytomegalovirus strain for human vaccination,” Infection and Immunity, vol. 12, no. 3, pp. 521–527, 1975.
- A. M. Arvin, P. Fast, M. Myers, S. Plotkin, and R. Rabinovich, “Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee,” Clinical Infectious Diseases, vol. 39, no. 2, pp. 233–239, 2004.
- S. A. Plotkin, M. L. Smiley, H. M. Friedman, et al., “Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants,” The Lancet, vol. 1, no. 8376, pp. 528–530, 1984.
- S. P. Adler, S. E. Starr, S. A. Plotkin et al., “Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age,” Journal of Infectious Diseases, vol. 171, no. 1, pp. 26–32, 1995, Erratum In Journal of Infectious Diseases, vol. 171, no. 4, p.1080, 1995.
- G. Hahn, D. Rose, M. Wagner, S. Rhiel, and M. A. McVoy, “Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique,” Virology, vol. 307, no. 1, pp. 164–177, 2003.
- J. C. Tamashiro and D. H. Spector, “Terminal structure and heterogeneity in human cytomegalovirus strain AD169,” Journal of Virology, vol. 59, no. 3, pp. 591–604, 1986.
- T. A. N. Cha, E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete, “Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains,” Journal of Virology, vol. 70, no. 1, pp. 78–83, 1996.
- M. N. Prichard, M. E. T. Penfold, G. M. Duke, R. R. Spaete, and G. W. Kemble, “A review of genetic differences between limited and extensively passaged human cytomegalovirus strains,” Reviews in Medical Virology, vol. 11, no. 3, pp. 191–200, 2001.
- A. J. Bradley, N. S. Lurain, P. Ghazal et al., “High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169,” Journal of General Virology, vol. 90, part 10, pp. 2375–2380, 2009.
- D. Wang and T. Shenk, “Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism,” Journal of Virology, vol. 79, no. 16, pp. 10330–10338, 2005.
- X. Cui, B. P. Meza, S. P. Adler, and M. A. McVoy, “Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection,” Vaccine, vol. 26, no. 45, pp. 5760–5766, 2008.
- S. P. Adler, S. H. Hempfling, S. E. Starr, S. A. Plotkin, and S. Riddell, “Safety and immunogenicity of the Towne strain cytomegalovirus vaccine,” Pediatric Infectious Disease Journal, vol. 17, no. 3, pp. 200–206, 1998.
- M. F. Stinski, “Cytomegalovirus and its replication,” in Fundamental Virology, B. N. Fields and D. M. Knipe, Eds., pp. 929–950, Ravem Press, New York, NY, USA, 2nd edition, 1991.
- D. Yu, G. A. Smith, L. W. Enquist, and T. Shenk, “Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene,” Journal of Virology, vol. 76, no. 5, pp. 2316–2328, 2002.
- M. A. McVoy, D. E. Nixon, and S. P. Adler, “Circularization and cleavage of guinea pig cytomegalovirus genomes,” Journal of Virology, vol. 71, no. 6, pp. 4209–4217, 1997.
- X. Cui, A. McGregor, M. R. Schleiss, and M. A. McVoy, “Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication,” Journal of Virological Methods, vol. 149, no. 2, pp. 231–239, 2008.
- J. C. Tamashiro, D. Filpula, T. Friedmann, and D. H. Spector, “Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA,” Journal of Virology, vol. 52, no. 2, pp. 541–548, 1984.
- C. Cunningham, D. Gatherer, B. Hilfrich et al., “Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens,” Journal of General Virology, vol. 91, part 3, pp. 605–615, 2010.
- W. Dunn, C. Chou, H. Li et al., “Functional profiling of a human cytomegalovirus genome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 24, pp. 14223–14228, 2003.
- E. Murphy, D. Yu, J. Grimwood et al., “Coding potential of laboratory and clinical strains of human cytomegalovirus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 14976–14981, 2003.
- A. Marchini, H. Liu, and H. Zhu, “Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes,” Journal of Virology, vol. 75, no. 4, pp. 1870–1878, 2001.
- A. Dolan, C. Cunningham, R. D. Hector et al., “Genetic content of wild-type human cytomegalovirus,” Journal of General Virology, vol. 85, part 5, pp. 1301–1312, 2004.
- C. A. Blankenship and T. Shenk, “Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect,” Journal of Virology, vol. 76, no. 23, pp. 12290–12299, 2002.
- A. J. Davison, A. Dolan, P. Akter et al., “The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome,” Journal of General Virology, vol. 84, part 1, pp. 17–28, 2003.
- P. Akter, C. Cunningham, B. P. McSharry et al., “Two novel spliced genes in human cytomegalovirus,” Journal of General Virology, vol. 84, no. 5, pp. 1117–1122, 2003.
- G. Hahn, M. G. Revello, M. Patrone et al., “Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes,” Journal of Virology, vol. 78, no. 18, pp. 10023–10033, 2004.
- M. Patrone, M. Secchi, L. Fiorina, M. Ierardi, G. Milanesi, and A. Gallina, “Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion,” Journal of Virology, vol. 79, no. 13, pp. 8361–8373, 2005.
- X. Cui, A. McGregor, M. R. Schleiss, and M. A. McVoy, “The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus,” Virology, vol. 386, no. 1, pp. 132–138, 2009.
- F. Zhou, Q. Li, and S. J. Gao, “A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes,” Nucleic Acids Research, vol. 37, no. 1, article e2, 2009.
- A. Macagno, N. L. Bernasconi, F. Vanzetta et al., “Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex,” Journal of Virology, vol. 84, no. 2, pp. 1005–1013, 2010.
- F. M. Saccoccio, A. L. Sauer, X. Cui et al., “Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells,” Vaccine, vol. 29, no. 15, pp. 2705–2711, 2011.